Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer

Background and objective Concurrent twice-daily radiotherapy with chemotherapy of EP regimen is one of the current standard treatments for limited-stage small cell lung cancer. However, the safely tolerated dose of standard chemotherapy for Chinese patients is not decided. This study was to evaluate...

Full description

Bibliographic Details
Main Authors: Jing YOU, Huiming YU, Maxiaowei SONG, Chen SHI, Xiaohang WANG, Ye ZHENG, Rong YU, Anhui SHI, Guangying ZHU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Limited stage small cell lung cancer
Concurrent chemo-radiotherapy
Accelerated hyperfractionation
Chemotherapy dose escalation
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.08

Similar Items

Similar Items